The Wistar Institute Receives $17 Million NIH Grant for Personalized HIV Cure Research

▤ Summary

The Wistar Institute received a five-year, $17 million NIH award to launch the iCure Consortium. The consortium will develop personalized HIV cure regimens by combining antibodies, mRNA therapy, viral binders, CAR-T cells, NK cells, and latency-reversing drugs. Researchers will tailor treatment strategies to each participant's HIV mutations and immune profile. The project involves multiple academic and clinical partners and builds on prior BEAT-HIV research efforts.

$ Funding

▦ Linked Companies